Small Populations, Big Challenges: Tackling Feasibility In Rare Disease Clinical Trials

By Jenna Morris and Elke Ydens, Anju Software

Rare disease clinical trials face distinct challenges due to small, geographically dispersed patient populations, limited historical data, and a scarcity of experienced investigators. The rarity of patients also delays diagnosis, making physician collaboration essential for participant identification. Innovative approaches and tailored solutions, such as TA Scan’s clinical intelligence platform, offer a transformative approach to addressing these complexities and enhancing enrollment strategies. Additionally, TA Scan’s global database and real-time insights empower teams to identify naïve investigators and extend networks beyond major academic centers.

With tools for targeting specialists, analyzing publication trends, and leveraging mentorship programs, TA Scan addresses the investigator scarcity in rare diseases while streamlining trial planning. By turning the unique challenges of rare disease trials into opportunities, this solution supports meaningful breakthroughs for the 300 million individuals impacted globally, accelerating access to life-changing therapies.